Buprenorphine And Naloxone Tablet
Product Images NDC 70518-3389

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 70518-3389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a pack of 30 tablets of Buprenorphine/Naloxone Sublingual, each containing 8mg/2mg strength. It is manufactured by Rhodes Pharma and repackaged by RemedyRepack for prescription use only (RX ONLY). The NDC number is 70518-3389-00, and the drug should be kept out of the reach of children. The lot number and expiry date are missing. The direction for use is available in the package insert, and federal law prohibits its transfer to anyone other than the patient. It should be stored at 20-26°C or 63-77°F with an excursion permit of 15-30°C or 50-86°F (as per USP).*

FDA Label Image

Chemical Structure (Buprenorphine 01)

HCI stands for Human-Computer Interaction, which is the study of how people interact with technology. It is an interdisciplinary field that combines techniques and theories from computer science, psychology, design, and other areas to create user-friendly and efficient computer systems. The goal of HCI is to improve user experience by making technology more intuitive, accessible, and responsive to users' needs and preferences.*

FDA Label Image

Chemical Structure (Buprenorphine 02)

FDA Label Image

Image (Buprenorphine 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.